Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ivan R Vogelius

Showing results (1-10 of 93) with videos related to

Pageof 10
Sort By:
International Journal of Radiation Oncology, Biology, Physics|February 28, 2018
Dose Response and Fractionation Sensitivity of Prostate Cancer After External Beam Radiation Therapy: A Meta-analysis of Randomized TrialsIvan R Vogelius, Søren M Bentzen
International Journal of Radiation Oncology, Biology, Physics|April 13, 2011
A prospective phase III randomized trial of hypofractionation versus conventional fractionation in patients with high-risk prostate cancer: in regard to Arcangeli C, et al. (Int J Radiat Oncol Biol Phys 2010;78:11-18)Ivan R Vogelius, Søren M Bentzen
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 11, 2011
A method to adjust radiation dose-response relationships for clinical risk factorsAne L Appelt, Ivan R Vogelius
International Journal of Radiation Oncology, Biology, Physics|March 5, 2013
In reply to Arcangeli et alIvan R Vogelius, Søren M Bentzen
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 4, 2021
Radiation Dose Escalation for Early Prostate Cancer: Reigniting the FLAME?Ivan R Vogelius, Søren M Bentzen
International Journal of Radiation Oncology, Biology, Physics|June 2, 2012
Meta-analysis of the alpha/beta ratio for prostate cancer in the presence of an overall time factor: bad news, good news, or no news?Ivan R Vogelius, Søren M Bentzen
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 30, 2014
Hypofractionated radiation therapy for prostate cancer: more food for thought from recent trialIvan R Vogelius, Søren M Bentzen
Neuro-Oncology|January 13, 2022
Proton vs photon radiation therapy for glioblastoma: Maximizing information from trialIvan R Vogelius, Søren M Bentzen
International Journal of Radiation Oncology, Biology, Physics|September 25, 2020
In Reply to Berk and AlfonsoIvan R Vogelius, Søren M Bentzen
International Journal of Radiation Oncology, Biology, Physics|January 29, 2020
Diminishing Returns From Ultrahypofractionated Radiation Therapy for Prostate CancerIvan R Vogelius, Søren M Bentzen
Pageof 10

Showing results (1-10 of 93) with videos related to

Sort By:
Pageof 10
International Journal of Radiation Oncology, Biology, Physics|February 28, 2018
Dose Response and Fractionation Sensitivity of Prostate Cancer After External Beam Radiation Therapy: A Meta-analysis of Randomized TrialsIvan R Vogelius, Søren M Bentzen
International Journal of Radiation Oncology, Biology, Physics|April 13, 2011
A prospective phase III randomized trial of hypofractionation versus conventional fractionation in patients with high-risk prostate cancer: in regard to Arcangeli C, et al. (Int J Radiat Oncol Biol Phys 2010;78:11-18)Ivan R Vogelius, Søren M Bentzen
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 11, 2011
A method to adjust radiation dose-response relationships for clinical risk factorsAne L Appelt, Ivan R Vogelius
International Journal of Radiation Oncology, Biology, Physics|March 5, 2013
In reply to Arcangeli et alIvan R Vogelius, Søren M Bentzen
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 4, 2021
Radiation Dose Escalation for Early Prostate Cancer: Reigniting the FLAME?Ivan R Vogelius, Søren M Bentzen
International Journal of Radiation Oncology, Biology, Physics|June 2, 2012
Meta-analysis of the alpha/beta ratio for prostate cancer in the presence of an overall time factor: bad news, good news, or no news?Ivan R Vogelius, Søren M Bentzen
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 30, 2014
Hypofractionated radiation therapy for prostate cancer: more food for thought from recent trialIvan R Vogelius, Søren M Bentzen
Neuro-Oncology|January 13, 2022
Proton vs photon radiation therapy for glioblastoma: Maximizing information from trialIvan R Vogelius, Søren M Bentzen
International Journal of Radiation Oncology, Biology, Physics|September 25, 2020
In Reply to Berk and AlfonsoIvan R Vogelius, Søren M Bentzen
International Journal of Radiation Oncology, Biology, Physics|January 29, 2020
Diminishing Returns From Ultrahypofractionated Radiation Therapy for Prostate CancerIvan R Vogelius, Søren M Bentzen
Pageof 10